ConductScience.org, home

Trial · NCT01974323

Results by group26

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Percentage of Patients With a Score of 0 (None) or 1 (Minimal) on the 5-point Global Acne Assessment Score (GAAS)Dapsone Gel29.8Percentage of Patients
Percentage of Patients With a Score of 0 (None) or 1 (Minimal) on the 5-point Global Acne Assessment Score (GAAS)Dapsone Gel Vehicle20.9Percentage of Patients
Change From Baseline in Inflammatory Facial Lesion CountsDapsone GelBaseline29.6Standard Error 0.23Number of Inflammatory Lesions
Change From Baseline in Inflammatory Facial Lesion CountsDapsone Gel VehicleBaseline30.0Standard Error 0.23Number of Inflammatory Lesions
Change From Baseline in Inflammatory Facial Lesion CountsDapsone GelChange from Baseline at Week 12-15.6Standard Error 0.35Number of Inflammatory Lesions
Change From Baseline in Inflammatory Facial Lesion CountsDapsone Gel VehicleChange from Baseline at Week 12-14.0Standard Error 0.35Number of Inflammatory Lesions
Change From Baseline in Noninflammatory Facial Lesion CountsDapsone GelBaseline46.7Standard Error 0.46Number of Noninflammatory Lesions
Change From Baseline in Noninflammatory Facial Lesion CountsDapsone Gel VehicleBaseline46.7Standard Error 0.46Number of Noninflammatory Lesions
Change From Baseline in Noninflammatory Facial Lesion CountsDapsone GelChange from Baseline at Week 12-20.8Standard Error 0.55Number of Noninflammatory Lesions
Change From Baseline in Noninflammatory Facial Lesion CountsDapsone Gel VehicleChange from Baseline at Week 12-18.7Standard Error 0.55Number of Noninflammatory Lesions
Change From Baseline in Total Lesion CountsDapsone GelBaseline76.4Standard Error 0.56Total Lesion Counts
Change From Baseline in Total Lesion CountsDapsone Gel VehicleBaseline76.9Standard Error 0.56Total Lesion Counts
Change From Baseline in Total Lesion CountsDapsone GelChange from Baseline at Week 12-36.2Standard Error 0.76Total Lesion Counts
Change From Baseline in Total Lesion CountsDapsone Gel VehicleChange from Baseline at Week 12-32.3Standard Error 0.75Total Lesion Counts
Percentage Change From Baseline in Total Lesion CountsDapsone Gel-48.9Standard Error 0.97Percent Change in Lesion Count
Percentage Change From Baseline in Total Lesion CountsDapsone Gel Vehicle-43.2Standard Error 0.97Percent Change in Lesion Count
Percentage of Patients Reporting Very Good or Excellent on Item 10 of the 5-Point Acne Symptom Impact Scale (ASIS)Dapsone Gel24.2Percentage of Patients
Percentage of Patients Reporting Very Good or Excellent on Item 10 of the 5-Point Acne Symptom Impact Scale (ASIS)Dapsone Gel Vehicle22.0Percentage of Patients
Change From Baseline in the 9-Item ASIS Sign Domain ScoreDapsone GelBaseline2.04Standard Deviation 0.627Scores on a Scale
Change From Baseline in the 9-Item ASIS Sign Domain ScoreDapsone Gel VehicleBaseline2.07Standard Deviation 0.612Scores on a Scale

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01974323/results